C12Y 304/24016
Neurolysin
Official title: Neurolysin (3.4.24.16)
C12Y304/24016 (Neurolysin) appears on 2 US grants and 6 published applications in this corpus.
Search patents in C12Y- Granted patents
- 2
- Published applications
- 6
- Assignees
- 6
- Inventors
- 12
- Latest grant
- 17 Jun 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2004 | 0 | 1 |
| 2005 | 0 | 0 |
| 2006 | 0 | 1 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 1 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 1 | 1 |
| 2015 | 0 | 0 |
| 2016 | 0 | 1 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 0 |
| 2021 | 0 | 1 |
| 2022 | 0 | 0 |
| 2023 | 0 | 0 |
| 2024 | 0 | 0 |
| 2025 | 1 | 0 |
By publication year.
Recent patents
- Enhancers of Neurolysin Activity1 Jul 2021US 2021/0198647 A1Texas Tech University System
- Methods for the Treatment and the Prognostic Assessment of Malignant Pleural Mesothelioma28 Jan 2016US 2016/0024206 A1Assistance Publique-Hopitaux de Paris
- Methods for the Treatment and the Prognostic Assessment of Malignant Pleural Mesothelioma25 Sep 2014US 2014/0286967 A1Assistance Publique-Hopitaux de Paris
- Methods for the Treatment and the Prognostic Assessment of Malignant Pleural Mesothelioma8 Dec 2011US 2011/0300161 A1INSERM (Institut National de la Sante et de Reche Medicale)
- Novel protease gene12 Oct 2006US 2006/0228362 A1Daiichi Pharmaceutical Co., Ltd.
Most cited
By later US patents